close Icon

Alcohol and Other Drugs

Co-Heads: Professor Paul Dietze and Associate Professor Peter Higgs.

Alcohol and other drug use is associated with a range of health and social harms conservatively estimated at costing the Australian community some $55 billion a year. Alcohol and other drugs are a major issue in Australia and Burnet has an established reputation in working to alleviate harms associated with their use.

Our main objectives are to:

  • Document the trajectories of alcohol and other drug use and key intervention points to reduce harms
  • Develop innovative studies to improve our understanding of patterns of alcohol and other drug use in the community
  • Develop, implement and evaluate new interventions to reduce alcohol and other drug related harms.

We conduct leading research on alcohol and other drug use and related harms in Australia. We work with a variety of at-risk populations, including young people and people who inject drugs.

Using innovative research designs and methods, the program has a strong history of collaboration with researchers from key national and international institutions.

The SuperMIX study: a longitudinal study funded by the NHMRC designed to examine patterns of drug use, health service use and health and social outcomes in a cohort of people who inject drugs (2008-2021).

  • Mobile Interventions to address Drinking in Young people (MIDY): a randomised trial funded by the NHMRC to develop a mobile-phone based intervention to reduce risky drinking by young people.
  • Burnet Institute received $2.5 million from the NHMRC to establish the Centre for Research Excellence into Injecting Drug Use (CREIDU). CREIDU brings together partners from research institutes, universities and community-based organisations across the country, with the aim of increasing out knowledge about injecting drug use, so we can identify ways to improve policy and practice in the area to reduce the severity of health and social outcomes associated with injecting drug use.
  • The Melbourne Injecting Drug User Cohort Study (MIX) has recruited almost 700 young heroin and methamphetamine injectors, who will be followed up annually to study trajectories of drug use, health service use and health and social outcomes over time. First-year follow-up interviews are complete with second and third year interviews now underway.
Paul Dietze Headshot 210X210

Professor Paul Dietze

Professor Paul Dietze is one of Australia’s leading alcohol and other drug epidemiologists with a significant national, and emerging international profile. He is an NHMRC Senior Research Fellow and a past ARC Future Fellow and VicHealth Public Health Research Fellow.

EMAIL CALL

Working
Group

Meet the working group. Together, we are translating research into better health, for all.

Projects

Holding Image
Feasibility study for a potential medically supervised injecting centre/drug consumption service for the ACT
PROJECT Arrow Icon
Holding Image
Investigating blood donation practices among people who inject drugs
PROJECT Arrow Icon
Holding Image
Liver Health Screening Test
PROJECT Arrow Icon
Shutterstock 212483335 510X288
MIDY: The Mobile Intervention for Drinking in Young People (pilot)
PROJECT Arrow Icon
Solomonf
Substance use and related harms among young people in the Solomon Islands
PROJECT Arrow Icon
IMG 0964 510X288
SuperMIX: The Melbourne Injecting Drug User Cohort Study
PROJECT Arrow Icon
Holding Image
Supervised Injecting Room Cohort study (SIRX)
PROJECT Arrow Icon
Holding Image
The Drug Policy Modelling Program (DPMP)
PROJECT Arrow Icon
Holding Image
Understanding patterns of methamphetamine use in Melbourne and rural Victoria, the VMAX study
PROJECT Arrow Icon
Holding Image
Understanding risky single occasion drinking and links to harms among young Australians
PROJECT Arrow Icon
Holding Image
Victorian Drug Trends
PROJECT Arrow Icon
Youngadult3
Young Adults and Alcohol Study
PROJECT Arrow Icon